Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Streamex Corp. Director's Dealing 2025

Apr 29, 2025

35540_dirs_2025-04-29_0981aa26-524d-4df0-8246-032606410f19.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2025-04-24

Reporting Person: Amato Anthony N. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-04-24 Common Stock A 23345 Acquired 2131547 Direct

Footnotes

F1: The shares of common stock were granted under the Company's 2023 Equity Incentive Plan in lieu of cash for Q4 2024 and Q1 2025 board fees and were fully vested as of April 24, 2025 (the "Date of Grant"), based on a closing price of $0.84 per share on such date.